|
1
|
Tang W, Patel ND, Wei X, Byrne D, Chitroda A, Narayanan B, Sienkiewicz A, Nummy LJ, Sarvestani M, Ma S, Grinberg N, Lee H, Kim S, Li Z, Spinelli E, Yang BS, Yee N, Senanayake CH. Synthesis of a Sodium–Hydrogen Exchange Type 1 Inhibitor: An Efficient Cu-Catalyzed Conjugated Addition of a Grignard Reagent to an Acetyl Pyridinium Salt. Org Process Res Dev 2013. [DOI: 10.1021/op300331b] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.4] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/29/2022]
Affiliation(s)
- Wenjun Tang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Nitinchandra D. Patel
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Xudong Wei
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Denis Byrne
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Ashish Chitroda
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Bikshandarkoil Narayanan
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Alexander Sienkiewicz
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Laurence J. Nummy
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Max Sarvestani
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Shengli Ma
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Nelu Grinberg
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Heewon Lee
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Soojin Kim
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Zhibin Li
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Earl Spinelli
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Bing-Shiou Yang
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Nathan Yee
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| | - Chris H. Senanayake
- Chemical Development, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, Connecticut 06877,
United States
| |
Collapse
|